GenoGenix LLC

Has GenoGenix LLC received an FDA warning letter about GLP-1 drugs?

Yes. FDA issued GenoGenix LLC a warning letter naming semaglutide, tirzepatide and retatrutide, dated Jan 20, 2026, with the FDA subject line “Compounding Pharmacy/Adulterated Drug Products.” openFDA also lists 4 drug recall reports for the firm naming semaglutide, tirzepatide and retatrutide.

FDA records in this index name GenoGenix LLC from Jul 30, 2025 to Jan 20, 2026. It is listed on FDA’s registered 503B outsourcing facility list: GenoGenix LLC, Raton, FL.

Names in FDA records
GenoGenix LLC; GenoGenix LLC
Type named in FDA records
Compounding pharmacy, 503B outsourcing facility
FDA warning letters
1
Drug recall reports
4
Drugs named
Semaglutide, Tirzepatide, Retatrutide
Latest record
Jan 20, 2026
503B location
Raton, FL
503B last inspection
Jul 18, 2025
Form 483 issued
Yes
Action on last inspection
Open

FDA warning letters

Later letters FDA listsLetter
Jan 20, 2026Compounding Pharmacy/Adulterated Drug ProductsSemaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov

A warning letter states FDA’s view when it was issued; it is not a court finding, and the company may have responded since. The later-letters column repeats what FDA’s warning letter index lists for each letter.

FDA’s summary excerpts

Drug recalls

Record
Jul 30, 2025Semaglutide for Injection, a) 20 mg b) 20 mg/mL, 10 mL Multi-Dose Vials, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as m...Lack of Assurance of SterilityClass IIOngoingD-0091-2026
Jul 30, 2025Semaglutide with B12 for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.Lack of Assurance of SterilityClass IIOngoingD-0083-2026
Jul 30, 2025Tirzepatide, 60mg/10 mL for Injection, 10mL vial lyophilized, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labe...Lack of Assurance of SterilityClass IIOngoingD-0092-2026
Jul 30, 2025Retatrutide for Injection, 60mg / 10mL vial, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692Lack of Assurance of SterilityClass IIOngoingD-0093-2026

FDA compounding inspections and actions

FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists one facility under this exact legal name. These entries cover all of the facility’s compounding, not only GLP-1 drugs.

GenoGenix, LLC, Boca Raton, FL (503B)

2 listed actions, including 1 Form 483 and 1 warning letter (2025 to 2026).

Document
Jan 20, 2026Warning letterWarning Letter (01/20/2026)fda.gov
Jul 18, 2025Amended Form 483Amended 483 Issued 07/18/2025fda.gov

A Form 483 lists investigator observations, not a final FDA determination. A warning letter states FDA’s view when it was issued, not a court finding; any close-out letter FDA lists is a row of its own.

Pharmacy pages with the same legal name, built from FDA’s 503B list and compounding inspections and actions page: GenoGenix, LLC, Boca Raton, FL, GenoGenix LLC, Raton, FL.

This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.